Quotient Therapeutics Secures $50 Million for Groundbreaking Genetic Research and More Fundings

Quotient Therapeutics , a Cambridge, Massachusetts-based startup focused on exploring genetic variation at the cellular level to identify novel #therapeutics, has successfully raised $50 million in funding. Flagship Pioneering , the incubator behind the company's inception, led this significant financial round.

Vivodyne , a pioneering startup based in Philadelphia and established two years ago, specializes in cultivating human tissues in laboratories for pre-clinical testing of new therapies. The company recently achieved a significant milestone by raising $38 million in a seed funding round. This financial injection was spearheaded by Khosla Ventures , accompanied by notable contributions from Bison Ventures , MBX Ventures, Kairos Ventures , and CS Ventures . #drugdiscovery

Cradle , an innovative 2-year-old startup based in Amsterdam, is at the forefront of leveraging #artificialintelligence to expedite and economize the design and engineering of proteins for scientists. Recently, the company secured a substantial $24 million in Series A funding. This financial boost was contributed by notable investors, including Index Ventures and Kindred Capital VC , and industry luminaries like Chris Gibson, co-founder of Recursion Pharmaceuticals, and Tom Glocer, ex-CEO of Thomson Reuters. With this latest round of funding, Cradle's total capital raised reaches an impressive $33 million.

Medmo , a six-year-old New York startup specializing in assisting consumers with scheduling #medicalimaging appointments, has successfully raised $9 million in funding. This round was led by Lerer Hippeau and included contributions from existing investors such as JERUSALEM VENTURE PARTNERS IV LP , C2 Ventures , and Stone IsraVentures.

Maia Oncology , a New York-based startup established this year specializing in virtual #cancer care coordination, has raised $4.25 million in a seed funding round. The round was co-led by Reed Jobs ' Yosemite and Takeda Digital Ventures . BrightEdge - American Cancer Society , BBG Ventures , and Coalition Operators also contributed to the investment.

Phare Health , a newly founded startup in London, utilizes large language models to extract data from clinical notes efficiently. This innovation aids hospitals in optimizing resource management and improving cost recovery. The company recently secured $3.1 million in seed funding, with General Catalyst leading the round. Additional financial support came from KHP Ventures and Bertelsmann Investments .

WASPITO , a Cameroon-based startup established three years ago, specializes in facilitating video consultations between patients and doctors, home collection of patient samples, and delivering medications. The company has recently raised $2.5 million in a seed extension round. This funding was contributed by a consortium of investors, including DP World , Saviu Ventures , AAIC Investment , Axian Ventures, and CFAO's next54 .

News

The United Kingdom has recently approved its first CRISPR gene-edited drug , and the United States is on the verge of following suit.